Sage Medical

Sage Medical (圣哲医疗) is a Qiming Venture Partners portfolio company that develops high-end energy surgical platforms, best known for its SA-series ultrasonic and advanced bipolar surgical devices . Its flagship SA100 system — an integrated ultrasonic/high-frequency surgical device combining ultrasonic scalpel and 7mm advanced bipolar vessel-sealing capability — received China's NMPA Class III registration in March 2025 and EU CE-MDR certification later that year, formally entering the European market; per Qiming's own writeup, it was the first domestic high-end energy platform to reach global markets in that product form . Its earlier SA10 system, featuring a plug-and-play design, had already won EU CE registration, completed its first European surgical use by early 2025, and subsequently obtained US FDA registration . The SA100's applications span general surgery, gynecology, and urology, and the company was named to VBData's 2026 Future Healthcare 100 .